Clinical Trials
3 trialsNCT01690065 2016-05-11
NICE-BORA
Ulsan University Hospital
Phase 2 Unknown
NCT01222143 2015-06-22
Safety and Efficacy Study of Nilotinib Combined With Mitoxantrone, Etoposide, and High-dose Cytarabine Induction Chemotherapy Followed by Consolidation for Patients With C-kit Positive Acute Myeloid Leukemia
University Health Network, Toronto
Phase 1/2 Terminated
NCT00762632 2012-08-08
Combination of Nilotinib (AMN107) and RAD001 in Patients With Acute Myeloid Leukemia
Technical University of Munich
Phase 1/2 Completed